Monks W Scott
Occupational Medicine Division, US Army Public Health Center, Aberdeen Proving Ground, Maryland.
US Army Med Dep J. 2018 Jan-Jun(1-18):60-66.
New materials are constantly being created to address the operational needs of the US Army. These materials provide challenges to occupational health practitioners by presenting unknown health risks and possible effects to workers they evaluate. The responsibility for developing a medical surveillance exam, as part of a comprehensive workplace surveillance program, may become the responsibility of the provider working in a clinic on a military installation where manufacturing, testing, and/or use of the material is being conducted. Insensitive munitions explosive (IMX) has presented such an opportunity for Army occupational medicine providers within the last few years. This article describes the course of action taken by the occupational health clinics, personnel of Army ammunition plants producing IMX-101, and the US Army Public Health Center-Army Institute of Public Health to address the situation of developing a medical surveillance examination during a time when little to no information existed about the components of this new explosive compound.
为满足美国陆军的作战需求，新型材料不断被研发出来。这些材料给职业健康从业者带来了挑战，因为它们会给从业者所评估的工人带来未知的健康风险和可能的影响。作为全面的工作场所监测计划的一部分，制定医学监测检查的责任，可能会落在在军事设施内的诊所工作的医疗服务提供者身上，该军事设施正在进行材料的制造、测试和/或使用。在过去几年里，钝感弹药炸药（IMX）就给陆军职业医学提供者带来了这样一个机会。本文描述了职业健康诊所、生产IMX - 101的陆军弹药厂人员以及美国陆军公共卫生中心 - 陆军公共卫生研究所为应对在几乎没有关于这种新型炸药化合物成分信息的情况下制定医学监测检查这一情况所采取的行动过程。
